title: Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up.
abstract: We studied the effects of carbamazepine (CBZ) (400 and 600 mg per day) in 10 patients with cerebellar tremors in a single-blind manner. All patients improved on a clinical rating scale and by accelerometric recording; there was no improvement with placebo. Our data suggest that CBZ may be a valuable drug in cerebellar tremors.
authors.affiliation: Department of Neurology, University of Sassari, Italy.
authors.forename: G P
authors.initials: GP
authors.lastname: Sechi
authors.forename: M
authors.initials: M
authors.lastname: Zuddas
authors.forename: M
authors.initials: M
authors.lastname: Piredda
authors.forename: V
authors.initials: V
authors.lastname: Agnetti
authors.forename: G
authors.initials: G
authors.lastname: Sau
authors.forename: M L
authors.initials: ML
authors.lastname: Piras
authors.forename: S
authors.initials: S
authors.lastname: Tanca
authors.forename: G
authors.initials: G
authors.lastname: Rosati
mesh_terms: D000328:Adult; D002220:Carbamazepine / Q000008:administration & dosage / Q000627:therapeutic use*; D002526:Cerebellar Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014202:Tremor / Q000188:drug therapy*
chemical_list: D002220:Carbamazepine